Background: Exercise right heart catheterisation (RHC) is the gold standard for diagnosis of HFpEF, however in its absence BNP constitutes part of the diagnostic criteria. A proportion of patients demonstrate low BNP values at rest despite elevated filling pressures at exercise, often attributed to body mass index (BMI) or renal function. We aimed to characterise the demographic, echocardiographic and haemodynamic features of patients with HFpEF and both a low and high BNP, at rest and exercise .
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Methods: 97 patients undergoing invasive RHC with haemodynamically confirmed HFpEF were included. BNP was measured immediately prior to catheterisation and echocardiography was performed simultaneously.
Results: 15% had a BNP value <35 pg/mL. Patients with a low BNP (<35) were of similar age 67 ± 9 vs 70 ± 9, p = 0.15), more likely to be female (74% vs 60%), and had a similar BMI (32 ± 6 vs 31 ± 7, p = 0.7) and creatinine (76 ± 15 vs 84 ± 26, p = 0.28). LA volume index was markedly lower (32 ± 7 vs 44 ± 14, p = 0.001). Low BNP patients had a slightly lower PCWP at rest (12 vs 14 mmHg, p = 0.02) which was similar at peak exercise (27 vs. 30 mmHg, p = 0.12). Peak exercise SBP was similar (186 vs 174 mmHg, p = 0.21). Peak cardiac index was significantly higher in those with a low BNP (5.8 ± 1.5 vs 4.2 ± 1.3 L/min/m2, p < 0.001).
Conclusion: Patients with HFpEF and a low BNP have similar peak pulmonary capillary wedge pressures but significantly higher augmentation in cardiac index. Resting natriuretic peptide levels may be closely linked with systolic dysfunction in HFpEF. Further studies are required to determine the diagnostic utility of natriuretic peptide levels in HFpEF, particularly in regard to the different haemodynamic phenotypes of the disease. Background: Secreted frizzled-related protein 5 (Sfrp5) has been described as a novel anti-inflammatory adipokine similar to adiponectin. Sfrp5 deficiency is associated with impaired metabolic phenotype, and hindlimb ischaemia. Furthermore, Sfrp5 deficiency leads to greater myocardial infarct size following ischaemia reperfusion injury with increased apoptosis and inflammation in the infarct zone. In this study, we aimed to examine expressions of Sfrp5 in human cardiac right atrial appendages (RAA); and the associated cardiac functional significance.
Methods and Results: A total of 21 right atrial appendage biopsies were collected from patients (mean age: 65 ± 8 years) who underwent coronary artery bypass graft (CABG). A majority of patients (91%) were male; 40% of patients had previous MI. Protein expressions of Sfrp5 were measured in tissue lysates using commercially available ELISA (MyBiosource) indexed for total sample protein levels. There was no difference in Sfrp5 levels in RAAs from patients with previous MI, or hypertension. Patients with diabetes had significantly lower RAA Sfrp5 levels (p = 0.02). On univariate analysis, there was no relationship between RAA Sfrp5 levels with age or BMI, or measure of cardiac diastolic function (E/E') (p = 0.07). On multivariate analysis, adjusted for age, BMI, previous MI, diabetes, hypertension, dyslipidaemia, low RAA Sfrp5 levels were significantly associated with high E/E' (β = −0.56, p = 0.01).
Conclusions: Sfrp5 is expressed in human cardiac tissue. Deficiency of cardiac Sfrp5 levels is associated with regulations of diastolic cardiac function. Our data are in support of the potential role of Sfrp5 in the pathogenesis of metabolicinduced cardiac dysfunction. http://dx.doi.org/10. 1016/j.hlc.2019.06.111 
